RINIDATE (Nova Pharmaceuticals Australasia Pty Ltd)
Product name
RINIDATE
Date registered
Evaluation commenced
Decision date
Approval time
125 (255 working days)
Active ingredients
methylphenidate hydrochloride
Registration type
New generic medicine
Indication
RIVATE / RINIDATE tablets are indicated for the treatment of ADHD. RIVATE / RINIDATE tablets are also indicated for the treatment of narcolepsy.